Figures & data
Table 1 Most relevant studies that found an association of psoriasis with specific pregnancy outcomes
Table 2 FDA pregnancy categories and inclusion of antipsoriasis drugs
Table 3 Main cohort studies exploring the effects of maternal exposure to topical corticosteroids
Table 4 Relevant data on the safety in pregnancy of topical noncorticosteroid agents used for psoriasis
Table 5 Relevant data on the safety in pregnancy of PUVA therapy, systemic corticosteroids, and cyclosporine
Table 6 Methotrexate and acitretin: reproductive safety risk and teratogenesis
Table 7 Characteristics of biologic drugs approved for psoriasis and safety data in pregnancy